Abstract
Summary1. Cynomolgus monkeys were treated with 5 mg/kilo of sodium monofluoroacetate on the day of, or 3 days following, subcutaneous inoculation of Type 1 poliomyelitis virus. 2. Nine of 42 monkeys which received drug on the Third day of virus resisted clinical infection as did 5 of 23 animals receiving drug on the third day after virus. All control animals became paralyzed. 3. Citrate did not accumulate in brain tissue of drug-treated monkeys suggesting that the action of fluoroacetate was at some site other than the brain. 4. The significance of these findings is discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
